MacroGenics, Inc. (MGNX)
4.05
-0.12
(-2.88%)
USD |
NASDAQ |
Aug 26, 16:00
4.05
0.00 (0.00%)
After-Hours: 16:49
MacroGenics 1 Year Total Returns (Daily) : 154.3% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 154.3% |
| August 24, 2026 | 137.9% |
| August 21, 2026 | 184.7% |
| August 20, 2026 | 173.2% |
| August 19, 2026 | 179.9% |
| August 18, 2026 | 169.1% |
| August 17, 2026 | 157.0% |
| August 14, 2026 | 160.5% |
| August 13, 2026 | 145.8% |
| August 12, 2026 | 173.5% |
| August 11, 2026 | 166.7% |
| August 10, 2026 | 164.9% |
| August 07, 2026 | 150.9% |
| August 06, 2026 | 149.1% |
| August 05, 2026 | 130.8% |
| August 04, 2026 | 137.8% |
| August 03, 2026 | 141.8% |
| July 31, 2026 | 136.5% |
| July 30, 2026 | 145.5% |
| July 29, 2026 | 132.3% |
| July 28, 2026 | 130.5% |
| July 27, 2026 | 133.9% |
| July 24, 2026 | 107.9% |
| July 23, 2026 | 121.5% |
| July 22, 2026 | 179.2% |
| Date | Value |
|---|---|
| July 21, 2026 | 208.8% |
| July 20, 2026 | 191.9% |
| July 17, 2026 | 191.6% |
| July 16, 2026 | 171.1% |
| July 15, 2026 | 189.9% |
| July 14, 2026 | 171.5% |
| July 13, 2026 | 179.5% |
| July 10, 2026 | 174.1% |
| July 09, 2026 | 187.4% |
| July 08, 2026 | 217.0% |
| July 07, 2026 | 249.3% |
| July 06, 2026 | 213.0% |
| July 02, 2026 | 241.3% |
| July 01, 2026 | 266.7% |
| June 30, 2026 | 281.8% |
| June 29, 2026 | 308.4% |
| June 26, 2026 | 278.7% |
| June 25, 2026 | 255.7% |
| June 24, 2026 | 256.7% |
| June 23, 2026 | 255.3% |
| June 22, 2026 | 249.6% |
| June 18, 2026 | 201.5% |
| June 17, 2026 | 189.1% |
| June 16, 2026 | 158.7% |
| June 15, 2026 | 171.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AbbVie, Inc. | 32.04% |
| Gilead Sciences, Inc. | 33.73% |
| Xencor, Inc. | 265.8% |
| Akari Therapeutics Plc | -77.77% |
| Janux Therapeutics, Inc. | -18.82% |